Literature DB >> 20635143

Preoperative biliary drainage before resection for hilar cholangiocarcinoma: whether or not? A systematic review.

Fei Liu1, Ya Li, Yonggang Wei, Bo Li.   

Abstract

BACKGROUND: The value of preoperative biliary drainage (PBD) before resection for hilar cholangiocarcinoma (HCCA) is still controversial nowadays. The objective of this review is to summarize quantitatively the evidence related to this issue.
METHODS: Two investigators independently searched the Medline, Embase, Academic Search Premier (EBSCO), Chinese BioMedical Literature on disc (CBMdisc), and Chinese Medical Current Contents (CMCC) databases. Eleven studies with a total number of 711 HCCA cases were included. Comparison was made of PBD versus no PBD in HCCA patients undergoing surgical resection. Outcome measures were postoperative complications, in-hospital death rate, postoperative infectious complications, and postoperative hospital stay.
RESULTS: There was no difference in death rate or postoperative hospital stay between the two treatment modalities. However, the overall postoperative complication rate and postoperative infectious complication rate were significantly adversely affected by PBD compared with surgery without PBD. In postoperative complications analysis, ten studies including 442 patients who underwent PBD and 233 patients who had no PBD were estimated. The odds ratio (OR) for postoperative morbidity was 1.67: 95% confidence interval (CI) [1.17, 2.39]. In postoperative mortality analysis, ten studies including 422 patients who underwent PBD and 238 patients who had no PBD were estimated. The OR for postoperative mortality was 0.70: 95% CI [0.41, 1.19]. In postoperative infectious complications analysis, five studies including 134 patients who underwent PBD and 122 patients who had no PBD were estimated. The OR for infectious morbidity was 2.17: 95% CI [1.24, 3.80]. In postoperative hospital stay analysis, only three studies with 84 patients who underwent PBD and 65 patients who had no PBD were estimated; the weighted mean difference (WMD) for postoperative hospital stay was 5.37 days: 95% CI [-1.78, 12.52 days].
CONCLUSIONS: This systematic review could not provide evidence for a clinical benefit of using PBD in jaundiced patients with HCCA planned for surgery. Preoperative drainage should not routinely be performed in patients with proximal bile duct cancer scheduled for surgical resection. Because of the lack of uniformity of this analysis, randomized controlled trials (RCTs) with large sample size and improved PBD techniques should be carried out to confirm our results.

Entities:  

Mesh:

Year:  2010        PMID: 20635143     DOI: 10.1007/s10620-010-1338-7

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  62 in total

1.  Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma--a single center experience.

Authors:  M F Gerhards; T M van Gulik; L T de Wit; H Obertop; D J Gouma
Journal:  Surgery       Date:  2000-04       Impact factor: 3.982

2.  Percutaneous transhepatic cholangial drainage: direct approach under fluoroscopic control.

Authors:  T Takada; F Hanyu; S Kobayashi; Y Uchida
Journal:  J Surg Oncol       Date:  1976       Impact factor: 3.454

3.  Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy.

Authors:  Hidetoshi Kanazawa; Masato Nagino; Satoshi Kamiya; Shunichiro Komatsu; Toshihiko Mayumi; Kenji Takagi; Takashi Asahara; Koji Nomoto; Ryuichiro Tanaka; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

Review 4.  Recent advances in the management of cholangiocarcinomas.

Authors:  J N Vauthey; L H Blumgart
Journal:  Semin Liver Dis       Date:  1994-05       Impact factor: 6.115

5.  Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience.

Authors:  Y Nimura; J Kamiya; S Kondo; M Nagino; K Uesaka; K Oda; T Sano; H Yamamoto; N Hayakawa
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

6.  Biliary decompression promotes Kupffer cell recovery in obstructive jaundice.

Authors:  W D Clements; M McCaigue; P Erwin; I Halliday; B J Rowlands
Journal:  Gut       Date:  1996-06       Impact factor: 23.059

7.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

8.  Mitochondrial dysfunction in the non-obstructed lobe of rat liver after selective biliary obstruction.

Authors:  M Kanai; M Tanaka; Y Nimura; M Nagino; T Katoh; T Ozawa
Journal:  Hepatogastroenterology       Date:  1992-10

Review 9.  Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system.

Authors:  E C Burke; W R Jarnagin; S N Hochwald; P W Pisters; Y Fong; L H Blumgart
Journal:  Ann Surg       Date:  1998-09       Impact factor: 12.969

10.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

View more
  30 in total

Review 1.  [Klatskin tumors: rational diagnostics and staging].

Authors:  U W Denzer; T Rösch
Journal:  Chirurg       Date:  2012-03       Impact factor: 0.955

2.  Hepatoprotective effect of ulinastatin in a rat model of major hepatectomy after obstructive jaundice.

Authors:  Xun Li; Jing Li; Yang-Jie Ou; Xiao-Xu Zhu; Xiao-Yu Yin; Yun-Xiao Zhu; Di Tang
Journal:  Dig Dis Sci       Date:  2015-02-03       Impact factor: 3.199

Review 3.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

Review 4.  The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Authors:  Neil Bhardwaj; Giuseppe Garcea; Ashley R Dennison; Guy J Maddern
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

Review 5.  Current status of preoperative biliary drainage.

Authors:  Junko Umeda; Takao Itoi
Journal:  J Gastroenterol       Date:  2015-07-03       Impact factor: 7.527

Review 6.  Preoperative biliary drainage in hilar cholangiocarcinoma: When and how?

Authors:  Woo Hyun Paik; Nerenthran Loganathan; Jin-Hyeok Hwang
Journal:  World J Gastrointest Endosc       Date:  2014-03-16

Review 7.  Outcome of stenting in biliary and pancreatic benign and malignant diseases: A comprehensive review.

Authors:  Benedetto Mangiavillano; Nico Pagano; Todd H Baron; Carmelo Luigiano
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

8.  Metal stents: a bridge to surgery in hilar cholangiocarcinoma.

Authors:  Dirk J Grünhagen; Declan F J Dunne; Richard P Sturgess; Nick Stern; Stephen Hood; Stephen W Fenwick; Graeme J Poston; Hassan Z Malik
Journal:  HPB (Oxford)       Date:  2012-10-16       Impact factor: 3.647

9.  Hilar cholangiocarcinoma: preoperative liver optimization with multidisciplinary approach. Toward a better outcome.

Authors:  Francesca Ratti; Federica Cipriani; Fabio Ferla; Marco Catena; Michele Paganelli; Luca A M Aldrighetti
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

Review 10.  Should preoperative biliary drainage be routinely performed for obstructive jaundice with resectable tumor?

Authors:  Chu Wang; Yiyao Xu; Xin Lu
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.